Literature DB >> 1861161

Kininogen and kinin in experimental spinal cord injury.

J Xu1, C Y Hsu, H Junker, S Chao, E L Hogan, J Chao.   

Abstract

Activation of the kallikrein-kinin system has been implicated in the pathogenesis of vasogenic brain edema and posttraumatic vascular injury. We determined the levels of kininogen and kinin in an experimental spinal cord injury model in the rat. Kininogen content in traumatized cord segments increased in a time-dependent manner. Western blot analysis showed that the kininogen in traumatized cord comigrates with 68K low-molecular-weight kininogen or T-kininogen. Trypsin treatment of the kininogen in traumatized cord released both bradykinin and T-kinin, which were separated by HPLC and quantified with a kinin radioimmunoassay. Endogenous kinin levels in the frozen spinal cord also increased up to 40-fold 2 h after injury as compared with controls. The results demonstrate an increased accumulation of kininogen and its conversion to vasoactive kinins in experimental spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1861161     DOI: 10.1111/j.1471-4159.1991.tb08246.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment.

Authors:  Hussein Abou-Abbass; Hisham Bahmad; Hadi Abou-El-Hassan; Rui Zhu; Shiyue Zhou; Xue Dong; Eva Hamade; Khalil Mallah; Abir Zebian; Naify Ramadan; Stefania Mondello; Jawad Fares; Youssef Comair; Samir Atweh; Hala Darwish; Kazem Zibara; Yehia Mechref; Firas Kobeissy
Journal:  Electrophoresis       Date:  2016-03-29       Impact factor: 3.535

Review 2.  Molecular aspects of kallikrein and kininogen in the maturing kidney.

Authors:  S S el-Dahr; S Dipp
Journal:  Pediatr Nephrol       Date:  1993-10       Impact factor: 3.714

3.  Evaluation of the neuroprotective effect of chrysin via modulation of endogenous biomarkers in a rat model of spinal cord injury.

Authors:  Amit D Kandhare; V Shivakumar; Anuchandra Rajmane; Pinaki Ghosh; Subhash L Bodhankar
Journal:  J Nat Med       Date:  2014-05-01       Impact factor: 2.343

Review 4.  Implication of the Kallikrein-Kinin system in neurological disorders: Quest for potential biomarkers and mechanisms.

Authors:  Amaly Nokkari; Hadi Abou-El-Hassan; Yehia Mechref; Stefania Mondello; Mark S Kindy; Ayad A Jaffa; Firas Kobeissy
Journal:  Prog Neurobiol       Date:  2018-01-31       Impact factor: 11.685

5.  Cardiovascular effects of intrathecally administered bradykinin in the rat: characterization of receptors with antagonists.

Authors:  P Lopes; D Regoli; R Couture
Journal:  Br J Pharmacol       Date:  1993-12       Impact factor: 8.739

6.  Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury.

Authors:  Jin-Moo Lee; Ping Yan; Qingli Xiao; Shawei Chen; Kuang-Yung Lee; Chung Y Hsu; Jan Xu
Journal:  J Neurosci       Date:  2008-03-19       Impact factor: 6.167

Review 7.  Development biology of the renal kallikrein-kinin system.

Authors:  S S el-Dahr
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

8.  Modulatory and plastic effects of kinins on spinal cord networks.

Authors:  S Mandadi; H Leduc-Pessah; P Hong; J Ejdrygiewicz; S A Sharples; T Trang; P J Whelan
Journal:  J Physiol       Date:  2016-02-15       Impact factor: 5.182

9.  Sensitization of neonatal rat lumbar motoneuron by the inflammatory pain mediator bradykinin.

Authors:  Mouloud Bouhadfane; Attila Kaszás; Balázs Rózsa; Ronald M Harris-Warrick; Laurent Vinay; Frédéric Brocard
Journal:  Elife       Date:  2015-03-17       Impact factor: 8.140

Review 10.  Kinin receptor antagonists as potential neuroprotective agents in central nervous system injury.

Authors:  Emma Thornton; Jenna M Ziebell; Anna V Leonard; Robert Vink
Journal:  Molecules       Date:  2010-09-20       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.